Doehner, W., Anker, S. D., Butler, J., Zannad, F., Filippatos, G., Coats, A. J. S., Ferreira, J. P., Henrichmoeller, I., Brueckmann, M., Schueler, E., Pocock, S. J., Januzzi, J. L., & Packer, M. (2024). Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial. JACC: Heart Failure, 12(12), 2057–2070. https://doi.org/10.1016/j.jchf.2024.08.020
